Novel Immunotherapies for Osteosarcoma

Osteosarcoma (OS) is the most common primary malignant bone sarcoma mainly affecting adolescents and young adults, which often progresses to pulmonary metastasis and leads to the death of OS patients. OS is characterized as a highly heterogeneous cancer type and the underlying pathologic mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yubao, Zhang, Jiahe, Chen, Yutong, Kang, Yuchen, Liao, Zhipeng, He, Yuanqi, Zhang, Cangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012135/
https://www.ncbi.nlm.nih.gov/pubmed/35433427
http://dx.doi.org/10.3389/fonc.2022.830546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012135/
https://www.ncbi.nlm.nih.gov/pubmed/35433427
http://dx.doi.org/10.3389/fonc.2022.830546

Ejemplares similares